This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Protein substance: Trastuzumab — humanised IgG1 monoclonal antibody targeting HER2
{
"resourceType" : "SubstanceDefinition",
"id" : "trastuzumab",
"identifier" : [{
"system" : "http://example.europa.eu/fhir/SMSId",
"value" : "TRAS9123H"
}],
"status" : {
"coding" : [{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}]
},
"classification" : [{
"coding" : [{
"system" : "http://example.europa.eu/fhir/SubstanceType",
"code" : "protein",
"display" : "Protein"
}]
}],
"domain" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Domain",
"code" : "human",
"display" : "Human use"
}]
},
"description" : "Trastuzumab — humanised IgG1 monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2/ErbB2). Variable regions derived from murine antibody 4D5, grafted onto human IgG1 framework. Produced in Chinese hamster ovary (CHO) cells.",
"code" : [{
"code" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Substance",
"code" : "TRAS9123H"
}]
}
}],
"name" : [{
"name" : "Trastuzumab",
"preferred" : true,
"language" : [{
"coding" : [{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}]
}],
"official" : [{
"authority" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-name-authority",
"code" : "INN",
"display" : "INN"
}]
},
"status" : {
"coding" : [{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}]
}
}]
},
{
"name" : "Herceptin",
"preferred" : false
}],
"protein" : {
"sequenceType" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-sequence-type",
"code" : "complete",
"display" : "Complete"
}]
},
"numberOfSubunits" : 2,
"disulfideLinkage" : ["HC22-HC96; HC144-HC200; HC222-LC214; HC228-HC228'; HC231-HC231'; HC265-HC325; HC371-HC429"],
"subunit" : [{
"subunit" : 1,
"sequence" : "EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS...",
"length" : 450,
"nTerminalModification" : {
"concept" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Modification",
"code" : "pyroglutamate",
"display" : "Pyroglutamic acid (pE)"
}]
}
},
"cTerminalModification" : {
"concept" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Modification",
"code" : "lysine-clipped",
"display" : "C-terminal lysine clipping"
}]
}
}
},
{
"subunit" : 2,
"sequence" : "DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK...",
"length" : 214
}],
"gene" : [{
"sequenceOrigin" : {
"coding" : [{
"system" : "http://hl7.org/fhir/gene-sequence-origin",
"code" : "humanised-mouse",
"display" : "Humanised mouse"
}]
},
"gene" : {
"concept" : {
"coding" : [{
"system" : "http://www.genenames.org",
"code" : "IGHG1",
"display" : "Immunoglobulin heavy constant gamma 1"
}]
}
}
}]
},
"relationship" : [{
"substanceDefinitionReference" : {
"reference" : "SubstanceDefinition/her2",
"display" : "Receptor tyrosine-protein kinase erbB-2 (HER2)"
},
"type" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-relationship-type",
"code" : "TherapeuticTarget",
"display" : "Therapeutic target"
}]
},
"interaction" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-interaction-type",
"code" : "binding",
"display" : "Binding"
}]
},
"measurementType" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-measurement-type",
"code" : "kd",
"display" : "Kd"
}]
},
"amountQuantity" : {
"value" : 0.1,
"unit" : "nM",
"system" : "http://unitsofmeasure.org",
"code" : "nmol/L"
}
}]
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.